>There is of course the less likely possibility that Teva was bluffing in the first place hoping to settle and not wanting to risk more damages (after all the litigation about the '579 patent is a tough one to win, even for Teva).<
Does anyone in Teva’s new inner circle play poker?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”